ANGELINE FISHER: Open Payments
NPI 1457902223 · NORTON SHORES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,987 in 134 payments from 40 companies in 2025. Trend: 2023 $1,711 · 2024 $2,243 · 2025 $2,987
Food & beverage: $2,987
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $302 |
| Merck Sharp & Dohme LLC | 7 | $208 |
| Eisai Inc. | 7 | $186 |
| Genentech USA, Inc. | 11 | $184 |
| JAZZ PHARMACEUTICALS INC. | 7 | $179 |
| Novartis Pharmaceuticals Corporation | 13 | $179 |
| Daiichi Sankyo Inc. | 7 | $149 |
| Ipsen Biopharmaceuticals, Inc | 4 | $115 |
| Tempus AI, Inc | 4 | $112 |
| Geron Corporation | 3 | $88 |
Products named: Lenvima, KEYTRUDA, Enhertu, Onivyde, XT CDX, ZEPZELCA, Polivy, RYTELO.
Industry payments across MI — which companies pay providers there.
